Replies to post #57453 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Just so everyone understands as this is right from Ariad's presentations, the '113 trial will not be fully ENROLLED with PATIENTS until Q3 of 2015. This can not be approved any earlier than the first half of 2016.

[greggors]

Jess, I took less than 12 months for NVS's alk imhibitor to be approved...March 13, 2013 to April 29, 2014...